These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Perventricular closure of perimembranous ventricular septal defects using the concentric occluder device. Wang S, Zhuang Z, Zhang H, Zhen J, Lu Y, Liu J, Xu Z. Pediatr Cardiol; 2014 Apr; 35(4):580-6. PubMed ID: 24196912 [Abstract] [Full Text] [Related]
4. Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children. Liu S, Zhang W, Li J, Wang S, Qian M, Shi J, Xie Y, Zhang Z. J Interv Cardiol; 2021 Apr; 2021():4091888. PubMed ID: 34621141 [Abstract] [Full Text] [Related]
7. Midterm Results of Transaxillary Occluder Device Closure of Perimembranous Ventricular Septal Defect Guided Solely by Transesophageal Echocardiography. Liang W, Zhou S, Fan T, Song S, Li B, Dong H, Zhang L, Hu M, Liu L. Heart Surg Forum; 2019 Mar 08; 22(2):E112-E118. PubMed ID: 31013220 [Abstract] [Full Text] [Related]
9. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: Midterm outcomes of the first middle-eastern experience. Haddad RN, Daou LS, Saliba ZS. Catheter Cardiovasc Interv; 2020 Sep 01; 96(3):E295-E302. PubMed ID: 31886940 [Abstract] [Full Text] [Related]
10. Very late-onset endocarditis complicated by non-significant aortic regurgitation after device closure of perimembranous ventricular septal defect. Tang C, Zhou K, Hua Y, Wang C. Medicine (Baltimore); 2020 May 01; 99(19):e20120. PubMed ID: 32384490 [Abstract] [Full Text] [Related]
12. Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study. Kuswiyanto RB, Gunawijaya E, Djer MM, Noormanto, Rahman MA, Murni IK, Sukardi R, Utamayasa A, Ardiansyah R, Nova R, Liliyanti S, Rahayuningsih SE, Anggriawan SL, Rahayuningsih TY, Koentartiwi D, Soewarniaty R, Yantie VK, Nugroho S, Hidayat T, Ontoseno T, Tobing TC, Ali M, Bashari MH, Yosy DS, Arafuri N, Hilmanto D, Yanuarso PB, Advani N, Sastroasmoro S, Putra ST. Glob Heart; 2022 May 01; 17(1):15. PubMed ID: 35342698 [Abstract] [Full Text] [Related]
16. Medium to long-term echo follow-up after ventricular septal defect device closure. Rahmath MR, Numan M, Dilawar M. Asian Cardiovasc Thorac Ann; 2016 Jun 01; 24(5):422-7. PubMed ID: 27112358 [Abstract] [Full Text] [Related]
17. Transcatheter Device Closure of Perimembranous and Intracristal Ventricular Septal Defects in Children: Medium- and Long-Term Results. Jiang D, Han B, Zhao L, Yi Y, Zhang J, Fan Y, Lv J, Wang J, Wang Y. J Am Heart Assoc; 2021 Jun 01; 10(11):e020417. PubMed ID: 33998288 [Abstract] [Full Text] [Related]
20. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM. Catheter Cardiovasc Interv; 2006 Oct 01; 68(4):620-8. PubMed ID: 16969878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]